Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07515755 · ClinicalTrials.gov registry record · NA
Supplemental Oxygen and Oxygen Desaturations in Colonoscopies
A NA study, sponsored by University of Utah.
- Not yet
- Registry status
- NA
- Development phase
- 280
- Enrollment target
NCT07515755: Clinical Trial NA study, sponsored by University of Utah.
NCT07515755 is a NA study that has not yet begun recruiting, run by University of Utah. The registered enrollment target is 280 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07515755, a NA study, has not yet begun recruiting, sponsored by University of Utah.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
Study Summary
This study will compare apnea and oxygen desaturation events among various methods of supplemental oxygen delivery during procedural sedation in colonoscopy patients. The goals of the study are to track apnea (10 or more seconds without respiration) and oxygen desaturation (hemoglobin oxygen saturation less than 90%) events in colonoscopy patients receiving one of three different methods of supplemental oxygen administration. The first method is standard-of-care continuous flow oxygen therapy, where a constant flow of oxygen is administered through a nasal cannula or oxygen mask. The second method is synchronized flow oxygen therapy. This is a delivery method implemented in an FDA-cleared medical device (Sovant, Dynasthetics LLC) which delivers variable-volume oxygen pulses only as the patient inhales. The delivered oxygen pulses are commensurate to the set flow rate and the patient's respiratory rate. The third method is continuous positive airway pressure therapy (CPAP), where non-invasive pressure support is given to the patient's airway to help keep their airway open. The hypothesis being tested is that synchronized flow delivery and CPAP therapy will demonstrate reductions in apnea and oxygen desaturation events compared to traditional continuous flow oxygen therapy.
Primary Outcome
The area under the hemoglobin oxygen saturation curve (AUC) will be calculated as the difference between the desaturation threshold of 90% and the recorded SpO2 integrated over the duration that SpO2 was below the 90% threshold.
Interventions
- DEVICE Control
- DEVICE CPAP
- DEVICE Breath-synchronized oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2026-05-18 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What is known before NCT07515755 opens enrollment
NCT07515755 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT07515755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07515755 about?
NCT07515755 is a clinical study titled "Supplemental Oxygen and Oxygen Desaturations in Colonoscopies". This study will compare apnea and oxygen desaturation events among various methods of supplemental oxygen delivery during procedural sedation in colonoscopy patients. The goals of the study are to track apnea (10 or more seconds without respiration) and oxygen desaturation (hemoglobin oxygen saturat...
What is the current status of trial NCT07515755?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2026-05-18. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT07515755?
The interventions under investigation include: Control (DEVICE), CPAP (DEVICE), Breath-synchronized oxygen (DEVICE).
Who is sponsoring clinical trial NCT07515755?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07515755's enrollment target sits among peer trials
280 380th of 2000 higher than 1,620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI